2- patients with rrecurring oral ulcer med... · size tiny pinhead sized (1 – 2mm) may coalesce...
TRANSCRIPT
2- Patients with rrecurring oral
ulcer 1-Recurrent Aphthous stomatitis
A-Minor form
B-Major form
C-Herpetiform
2- Behcet’s disease
3- Recurrent herpes simplex virus infection
A-Recurrent intraoral herpes
B-Recurrent herpes labialis
Minor form 80% Herpetiform 10%
Aphthous ulcers
Major form 10%
Definition:- Painful, single or multiple recurring
ulceration, commonly affect the non keratinized oral
mucosa Prevalence:- the most common lesions of the mouth after
caries and periodontal diseases
Age:- childhood and teenagers. Sex:- Females more than males.
Site:- more in non keratinized mucosa and rare on keratinized mucosa
Types
Minor Aphthous ulceration
prodromal
features 24 hours
tingling and
burning
sensation
Erythematous
macule or
papules
Necrosis of
the covering
epithelium
Sloughing of
the necrotic
epithelium
Aphthous
Ulceration
Healing in
10-14 days by
epithelization
from the
margin with
no scar
Minor Aphthous ulcers
Chief complain Rate of recurrence
First:- very painful
due to tissue
destruction.
Later on:- 4-6 days,
discomfort due to
decreased tissue
destruction and the
ulcer had reached its
maximum size.
Frequent: every month
or every few months.
Infrequent:- once or
twice every year or
several years.
In some persons:- there
is no ulcer free period.
i.e. development of new
ulcers during the healing
of the previous ones.
Major Aphthous ulceration
(periadenitis mucosa necrotica recurrence)
prodromal features
fever, headach,
maliase and
regional
lymphadenopathy
Erythematous
macule or
papules
Necrosis of
the covering
epithelium
Sloughing of
the necrotic
epithelium
Aphthous
Ulceration
Healing after few
months with scar
due to destruction
of the deep tissues.
A cobblestone
appearance due to
continuous recurrence
and multiple scaring
Major Aphthous ulcers (periadenitis mucosa necrotica recurrence)
Chief complain Rate of recurrence
@ Interference with
mobility of tongue
and uvula.
@ Difficulty in eating
and swallowing. This
due to:-
• deep destruction.
• slow healing.
•Scar formation.
The lesions may last for
few months, with
tendency to form
elevated margin for the
ulcer.
So; it may be mistaken
as a malignant ulcer.
N.B. several minor ulcers may coalesce
to form larger ulcer more than 1cm but
in this case isn't considered to be MAU
Major aphthous ulcers Minor aphthous ulcers
solitary or multiple 1 - 6 Number
any where especially soft
palate & tonsillar areas
Common on non
keratinized mucosa
Rare on keratinized
Sites
Irregular Rounded (lip and cheek)
oval(vestibules) Shape
larger than 1 cm less than 1 cm Size
leave scars formation healing without scarring Scar formation
lymph nodes enlargement No lymph nodes
enlargement lymph nodes
Deeper in C.T, minor
salivary glands, facial
muscles
shallow Depth
Raised due to edema, shiny
and erythematous
Slightly raised, regular and
erythematous Margins
Covered by gray slough Covered by grayish or
yellowish white fibrinous
exudate
Floor
Indurated Non indurated Base
The least common variant of RAS. Not preceded by vesicles as HS
Multiple (dozen) Number
Tiny pinhead sized (1 – 2mm) may coalesce forming larger ulcer. Size
Extremely painful, interfere with eating and speaking Chief Complaint
Non keratinized mucosa,
Tongue (lateral margin and tip)
Floor of the mouth.
Site
Quicker than MAU and MiAU, without scar healing
The whole cycle takes 3 -4 days with the development of new crops,
the whole cycling pattern takes 2 weeks.
duration
Frequent:- development of new set of ulcers that overlaps the
previous group.
Spontaneous remission:- occurs after 5 years.
Recurrence Rate
Herpetiform Aphthous Ulceration
Histopathological features
• Preulcerative stage:- T4 lymphocytes
accumulates in submucosa and around
blood vessels.
• Ulcerative stage:-
@ T8 begin to dominate.
@ Extravasation of RBCs and neutrophils.
@ Mast cells and macrophages are present
in the ulcer base.
Etiology • Although the primary cause is unknown RAU may
be attributed to:-
1- Hereditary
Factors:-
• Occur more
frequently in
related persons.
•Frequent
association with
MHC class II.
2- Immunological factors:-
A- Cell mediated cytotoxic reaction; these
reactions are against oral epithelial cells.
Mediated by neutrophils, natural killer
cells and T-cytotoxic cells.
B- Alteration of Ts/Th cells ratio.
C- Local immune complex reaction:-
antigen +antibody deposited around blood
vessels and activate the complement.
3- Aphthous ulcer may be
associated with :
A- Hematological deficiencies,
deficient folate, Vit.B12,
zinc, iron and deficiency in
circulating neutrophils.
B- GIT diseases:- ulcerative
colitis and Crohn’s disease.
C- Allergic factors:- atopy, drug
and food allergy.
D- Behcet’s disease.
E- AIDs.
F- FAPA syndrome in children
less than 5 years
4- Recurrence
precipitated by:-
A- Trauma.
B- Hormonal changes;
decreasing oestrogen and
increasing progesterone.
During menstruation,
ulcers fall during
pregnancy and
exacerbated during
menopause.
C- Emotional factors:-
increased incidence
during examination
Treatment of RAU
1- RAU secondary to systemic disease:-
As:- @ Chronic inflammatory bowel diseases.
@ Cyclic neutropenia.
@ Behcet’s disease.
@ FAPA syndrome.
@ Aids.
@ Iron and Folate deficiency.
Treatment of the underlying systemic disease.
Treatment of RAU
2- RAU unrelated to systemic disease:-
The treatment is directed toward controlling
rather than curing of the lesion.
First step;- is patient education regarding
the:-
@ Nature of the disease.
@ Clinical course of the disease.
@ Recurrence.
@ Aim of the drug prescribed.
Treatment of RAU
2- RAU unrelated to systemic disease:-
Second step;- active treatment of the ulcers
A- Corticosteroids:-
1- Topical steroids:-
Used for 2 months
(for MAU) used as
mouth bath or
aerosol.
With antifungal drug
one week out of every
4 weeks
2- Short course
systemic steroids
(for MAU):- 20-
40mg predisone
1.5hrs after arising
as single dose for 5 -
7 days reduced to
10-20mg over the
next few days
3- Intralesional
injection of
steroid:- ulcer
resistant to healing
for 5-7 days.
10-20mg injectable
triamcinolone
acetonide diluted to
0.5-1ml with 2%
lidocain, used 2-
3times/week
1) Topical corticosteroids Start with weak preparations
hydrocortisone hemisuccinate lozenges 2.5 mg q.d.s.
0.1% triamcinolone ointment in
orabase q.d.s
0.1% - 0.2% triamcinolone
acetonide mouth wash
Mouth rinse, prepared by the pharmacist from injectable triamcinolone
acetonide and distilled water. The patient is advised to use 5ml as mouth rinse
q.d.s.
this provides:-
* ease of use
* wide spread
*effective application compared with cream or ointments or lozenges.
4- betamethasone 0.1 mg lozenges q.d.s.
5- Betamethasone valerate
aerosol
effective in mild cases
All topical corticosteroids should be applied four times per day
after meal time and at bed time and to take nothing by mouth for
at least one hour after application of the drug
2) systemic corticosteroids
High dose (20 - 40 mg) of
prednisone given as a single
dose daily 1.5 hour after
arising for 5 – 7 consecutive
days, followed by 10 – 20 mg
1.5 hours after arising every
other morning for additional 2
weeks.
short course of systemic
steroid to supplement the
topical steroid specially in
case of ulceration.
3- intralesional steroid injection:-
Used in resistant ulcers.
2-3 injections weekly starts 5-7 days after topical or systemic steroid therapy.
10 – 20 mg of injectable triamcinolone acetonide diluted to 0.5 – 1 ml with lidocaine 2% because steroid injection is very painful.
Treatment of RAU
2- RAU unrelated to systemic disease:-
Second step;- active treatment of the ulcers B- Tetracycline mouth bath:- C- the dentist should avoid
D- the patient should avoid
Tetracycline + nystatin
(Mysteclin capsules)
or Tetracycline +
amphotericin (Mysteclin
syrup); dissolved in 5ml of
water/3minutes/t.d.s better to
be followed by topical steroids.
The best line for treatment of
herpetiform AU
Using silver nitrate, phenol and
other caustics in treatment of
aphthous ulcer, this will relief pain
but it delay healing and enhance
healing with scar.
Consuming irritating
substances , it causes pain
Summary of treatment of RAU
A- Mild to moderate cases:- B- Severe cases:-
D- the patient should avoid
1- Analgesic before eating to
releif pain, lidocain gel, or
benzydamine hydrochloride as
mouth bath.
2- Ora base (sodium carboxy
methyl cellulose), topical
steroids, chlortetracycline
mouth bath/after eating and bed
time.
3- Short course of non-steroidal
anti-inflammatory drug as adjunct.
1- Chloretetracycline mouth
bath followed by potent
topical steroid after eating and
at bed time.
2- Systemic corticosteroid.
3- Intra-lesional injection of
steroids.
4- Dapsone may be tried in
Major AU.
iii-Dapsone:- (Malaria, pneumocystis
carinii and leprosy)
Used in severe bullous – erosive lesions.
Control T lymphocyte mediated process.
Modulates the release of inflammatory chemotactic factors from mast cells or neutrophils.
Treatment
1- Treatment of under lying systemic diseases
2- Corticosteroids:
a- Systemic b- Topical
3 -Tetracycline mouth bath.
4-Dentist should avoid irritating substances as
phenol.
5-Patient should avoid citrus fruits & spiced food.